About the Company
We do not have any company description for Enfusion, Inc. at the moment.
Exchange
NYSE
Fundamental Data and Insider Transactions (Quarterly data) Full Screen
Loading the fundamentals chart...
Latest News on Enfusion, Inc.
Enfusion, Inc. Reports Strong Q3 2024 Results - Nasdaq
Enfusion, Inc. ( (ENFN) ) has released its Q3 earnings. Here is a breakdown of the information Enfusion, Inc. presented to its investors.Enfusion, Inc. operates as a unique collaboration platform ...
Enfusion (ENFN) Moves 5.0% Higher: Will This Strength Last?
Enfusion, Inc. ENFN shares rallied 5% in the last trading session to close at $8.98. This move can be attributable to notable volume with a higher number of shares being traded than in a typical ...
Should You Believe in Enfusion’s (ENFN) Healthy Revenue Growth And ...
On August 29, 2024, Enfusion, Inc. (NYSE:ENFN) stock closed at $8.20 per share with a market capitalization of $764.328 million. NCG Small Cap Strategy stated the following regarding Enfusion, Inc ...
Enfusion, Inc. (ENFN) Investigation: Bronstein, Gewirtz & Grossman, LLC ...
Investigation Details On August 6, 2024, Enfusion reported its financial results for the second quarter of 2024. The Company missed consensus estimates for both earnings and revenue.
ENFN Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of ...
Halper Sadeh LLC, an investor rights law firm, is investigating whether the sale of Enfusion, Inc. (NYSE: ENFN) to Clearwater Analytics for $5.85 per ...
Clearwater Analytics to Acquire Enfusion for $1.5 Billion
BOISE, Idaho and CHICAGO, Illinois – January 13, 2025 – Clearwater Analytics (NYSE: CWAN) (“Clearwater”) and Enfusion, Inc. (NYSE: ENFN) (“Enfusion”) today announced their entry into a definitive ...
Enfusion, Inc. (ENFN) Shareholders May Have Been Affected by Fraud ...
Enfusion conducted its initial public offering ("IPO") on or around October 21, 2021, selling 15.32 million shares of stock priced at $17.00 per share.
Enfusion, Inc. (ENFN) Q4 2023 Earnings Call Transcript
Enfusion, Inc. (ENFN) Q4 2023 Earnings Conference Call March 12, 2024 8:30 AM ETCompany ParticipantsBill Wright - Head, IROleg Movchan - CEOBrad Herring - ...
Tower Research Capital LLC TRC Grows Holdings in Enfusion, Inc. (NYSE ...
Enfusion, Inc. has a 1-year low of $7.83 and a 1-year high of $11.80. The company has a market cap of $1.40 billion, a P/E ratio of 271.29, a PEG ratio of 1.85 and a beta of 0.92.
Clearwater Analytics to Acquire Enfusion for $1.5 Billion Expanding its ...
Enfusion's financial results for and as of the year ended December 31, 2024, presented in this press release are preliminary, unaudited, and based on currently available information.
Similar Companies
Loading the latest forecasts...